Skip to content
Get started

6857.T

Advantest Corp.

  • sector: Semiconductor Equipment
  • in 9 Arithmos indices

Themes 6857.T appears in

Indices that include 6857.T 9/9

sort
weight≥ 0.0%
alongside
  1. #1

    The Huang Index — NVIDIA's Critical Dependency Chain (Sole-Source & Ecosystem Tilt)

    6857.T , 4.72%2330.TW000660.KSASML.AS005930.KS+15 more

    Near-monopoly in high-end SoC/HBM test equipment — every GPU and HBM stack is tested on Advantest gear. 39% growth and 57% ROE support a solid mid-tier weight.

    CAGR
    120.5%
    Sharpe
    1.65
    max DD
    -39.1%
  2. #2

    Arithmos AI Picks and Shovels Index, Growth and Scale Blended

    6857.T , 3.65%NVDA2330.TWMU000660.KS+15 more

    AI chip test equipment supplier with 39.3 percent revenue growth, a 65.7 percent gross margin and a 56.9 percent ROE. Raised from 3.6 percent on that quality profile, with a 1.19 beta that is among the lowest in the semiconductor sleeve.

    CAGR
    115.7%
    Sharpe
    1.60
    max DD
    -39.2%
  3. #3

    Global AI Compute & Data-Centre Index — 15 Leaders (Cap + Growth Tilt)

    6857.T , 3.00%NVDA2330.TWAVGO000660.KS+10 more

    AI chip test equipment leader with 39% growth and 57% ROE. Smaller weight reflecting a narrower, more cyclical test-equipment niche.

    CAGR
    45.6%
    Sharpe
    1.09
    max DD
    -53.5%
  4. #4

    Global AI Compute & Data-Centre Index — 15 Leaders, Size-and-Growth Tilted

    6857.T , 2.00%NVDA2330.TWAVGO000660.KS+10 more

    Dominant AI-chip test equipment supplier; 39% revenue growth and 57% ROE. A high-quality but smaller-cap niche, so a small satellite weight.

    CAGR
    45.6%
    Sharpe
    1.11
    max DD
    -52.1%
  5. #5

    Arithmos AI Picks & Shovels Index — Global Compute Supply Chain (Conviction-Weighted, 20 Names)

    6857.T , 3.57%NVDA2330.TWMU000660.KS+15 more

    AI chip test equipment — a hard-to-substitute step in the HBM/accelerator flow: 39.3% revenue growth, 65.7% gross margin, 56.9% ROE. Small weight for a 54.6x P/E and a 97% run already booked.

    CAGR
    44.3%
    Sharpe
    1.13
    max DD
    -50.7%
  6. #6

    Future of AI — Global 20 (Cap + Growth Tilted)

    6857.T , 2.94%NVDAMSFTGOOGAVGO+15 more

    Dominant AI chip test equipment supplier with 39.3% growth and 56.9% ROE. Strong quality earns a mid-low weight.

    CAGR
    42.9%
    Sharpe
    1.10
    max DD
    -50.8%
  7. #7

    Global Physical AI Leaders Index — Size & Quality Tilted

    6857.T , 8.00%NVDA8035.T6861.T6501.T+10 more

    Advantest dominates semiconductor test equipment for AI accelerators with 39% revenue growth, 66% gross margin and 57% ROE — the strongest quality profile here. High growth and quality justify a top-tier weight.

    CAGR
    41.5%
    Sharpe
    1.11
    max DD
    -49.4%
  8. #8

    Global Physical AI Leaders Index — Size & Growth Tilted

    6857.T , 5.00%NVDA2330.TW005930.KSTSLA+10 more

    Advantest makes the semiconductor test equipment essential to validating AI chips. 57% ROE, 39% growth, and the strongest 1Y return in the set (~213%); 5% weight for its high-growth test-equipment niche.

    CAGR
    39.5%
    Sharpe
    1.08
    max DD
    -50.8%
  9. #9

    Owner Earnings 15% IRR Portfolio, SBC Adjusted, Growth Capped at Trimmed 4 Year Average

    6857.T , 1.68%GOOGMETAMSFTNVDA+32 more

    56.9% ROE and 65.7% gross margin on 39.3% revenue growth with only 0.10 debt to equity, the strongest fundamental profile in the Japanese sleeve. Gets the smallest weight in the group because the 51.3 P/E and 733% 3Y return make it the most extended holding, so the trimmed growth cap cuts the modelled IRR the hardest.

    CAGR
    22.8%
    Sharpe
    1.39
    max DD
    -9.3%

Build your own index that includes 6857.T.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

A research tool, not investment advice. Past performance doesn't guarantee future results. Learn more